ARCA BIOPHARMA ANNOUNCES AB201 DEVELOPMENT PROGRAM FOR TREATMENT OF COVID-19 ASSOCIATED COAGULOPATHY Posted on May 28, 2020 by ARCA IT - Press Release, Uncategorized AB201-Development-for-COVID-19-FINAL
CLINICAL DATA EVALUATING GENCARO FOR THE TREATMENT OF ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS FEATURED IN THREE PRESENTATIONS AT THE 2020 HEART RHYTHM SCIENTIFIC SESSIONS Posted on May 7, 2020 by ARCA IT - Press Release, Uncategorized Gencaro-Data-at-HRS-2020
ARCA BIOPHARMA ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Posted on May 6, 2020 by ARCA IT - Press Release, Uncategorized ARCA-1Q20-Financial-Results-and-Business-Update